awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42371566-39D17103-0EAE-49B5-B4F9-2836B8098388
Q42371566-39D17103-0EAE-49B5-B4F9-2836B8098388
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42371566-39D17103-0EAE-49B5-B4F9-2836B8098388
VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma.
P2860
Q42371566-39D17103-0EAE-49B5-B4F9-2836B8098388
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42371566-39D17103-0EAE-49B5-B4F9-2836B8098388
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8cccb9b4b676043a7817a5eb4262b8a91d2c4e88
P2860
Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line.